Transcript Highlights:

• We can track pharmacies, but the pharmacies are not the ones filling the prescriptions to pharmacists
• We can track pharmacies, but the pharmacies are not the ones filling the prescriptions to pharmacists
• It controls pharmacies, but you have pharmacies within assisted living facilities or nursing facilities
• I've been four years now on the Board of Pharmacy.
• controls pharmacies, but you have pharmacies within assisted living facilities or nursing facilities

Summary: The committee met as a Joint Health and Human Services Committee of Reference to hear sunset reviews and performance audit findings for several health-related boards. The first action taken was on the Arizona State Board of Pharmacy. The Auditor General reported that while the board met some licensing deadlines, it had significant problems enforcing controlled substances prescription monitoring program (CSPMP) requirements, timely investigating complaints, and documenting fee analyses and other compliance items. The board director said the agency had implemented some recommendations, was seeking legislative help on CSPMP enforcement and data issues, and described staffing and vendor challenges. A public member testified that the board was generally efficient but that statutory gaps limited its effectiveness. The committee then voted 13-0, with six not voting, to continue the Board of Pharmacy for six years until July 1, 2032, with statutory changes to improve its operations. The committee next reviewed the Arizona State Board of Nursing. The Auditor General found the board timely processed licenses but continued to resolve too many complaints late, with a large and growing backlog of open cases, and identified additional issues in oversight, accounting, public records, and conflict-of-interest practices. The executive director said the board had been under-resourced as nursing volume and complaints increased, requested 28 additional investigative positions, and described efforts to triage cases and improve tracking. The Arizona Nurses Association supported the board’s role and said it was working on a bill, House Bill 2408, to improve accountability, prioritization, and fairness in the disciplinary process. A nurse attorney testified that changes to complaint notice, the scope of investigations, and triage could shorten delays. The committee approved continuation of the Board of Nursing for four years until July 1, 2030, by a 14-0 vote with five not voting. The committee then heard the sunset review for the Arizona Board of Occupational Therapy Examiners. The Auditor General reported that the board generally met licensing timelines but had documentation problems verifying fingerprint clearance cards or criminal history checks, and it failed to act promptly on a renewal application involving serious sex-trafficking-related charges. The board said it had accepted all recommendations, had implemented most of them, had moved to a new licensing platform, and had hired help to address rulemaking delays. Members asked about fingerprint verification and the handling of the serious criminal charges. The committee voted 16-0 to continue the board for four years until July 1, 2030, with statutory changes to improve its performance. Finally, the committee began the review of the Arizona Regulatory Board of Physician Assistants. The Auditor General found the board had met some licensing and enforcement requirements but lacked adequate executive oversight, accountability, and tracking systems, and it had very high complaint-resolution delays. The report also criticized the board’s incentive pay structure, which paid all staff based on measures unrelated to complaint timeliness. The new executive director said the board had created formal investigative timelines, improved reporting, sought additional support staff, and was updating IT and incentive metrics; she also explained that the board is a shared agency with the Medical Board. The transcript ends during this presentation, before any vote on the physician assistant board is shown.

Transcript Highlights:

• We also partner with our MedImpact pharmacy benefit manager, um, because they look at pharmacy first
• </c> with our with Med impact our Pharmacy with our with Med impact our Pharmacy benefit<00:30:16.840
• > comes</c><00:30:20.960><c> to</c> Pharmacy first before Pharmacy comes to Pharmacy first before Pharmacy
• </c> organizations so we have one uh Pharmacy organizations so we have one uh Pharmacy benefit<00:36:
• </c> claims activity we also have a pharmacy claims activity we also have a pharmacy and<00:37:15.160

Keywords: 958, all

Summary: The subcommittee met to review the Department for Medicaid Services’ program integrity work. Commissioner Lisa Lee and Program Integrity Director Jennifer Dudinsky outlined Kentucky Medicaid’s structure, funding, enrollment, and spending, including FMAP rates, the size of the Medicaid and KCHIP populations, the number of providers, and 2024 expenditures. They also described the managed care and fee-for-service populations, noting that managed care serves most members while fee-for-service is concentrated in long-term care and waiver populations. Most of the discussion focused on fraud, waste, abuse prevention, and provider oversight. The department described its provider enrollment and certification checks, revalidation requirements, site reviews, fingerprinting for some high-risk providers, and termination grounds such as false application information, Medicare actions, unreported ownership changes, and abandonment of a provider number. Members asked about nonprofit ownership reporting, MCO fraud oversight, and how the department tracks unusual CPT code utilization, especially in behavioral health. The department said it uses data analytics, audits, policy review, and collaboration with behavioral health staff to monitor those trends. Dudinsky explained the division’s four branches: provider licensing and certification, audits and compliance, recovery, and third-party liability/estate recovery. She described prepayment and postpayment audits, referrals of credible fraud allegations to the Attorney General, monthly meetings with the AG’s office, and coordination with the Office of Inspector General, CMS, HHS OIG, MCOs, and other partners. She also explained payment suspensions, stand-downs during law enforcement investigations, and recovery efforts for overpayments, provider/member fraud, and third-party liability. The department said its recovery and avoidance efforts produced more than $251 million in savings so far in 2025. No votes or formal actions beyond approving the minutes were taken.

Transcript Highlights:

• It allows for CGMs to be billed by both pharmacy and durable medical equipment providers.
• Pharmacy and durable medical equipment providers. It is already live with our system.
• So my understanding, you correct me, I hope, is that it's instantaneous basically for pharmacy.
• We're also setting up a process by which we allow the pharmacy alert the pharmacy that they cannot bill
• And now what you're saying is they're going to go through pharmacy for these.

Summary: The committee reviewed a series of Arkansas DHS and Department of Health rules, most tied to 2025 legislation. Early items covered Medicaid changes including presumptive eligibility application timing, adding a fictive kin definition for foster child eligibility, raising the able account disability onset age to 46, allowing continuous glucose monitors to be billed by both pharmacy and DME providers, increasing the RSV vaccine administration fee for children, a telemedicine exemption for ET3 ambulance services, and a physical therapy access rule that also included occupational therapy. Members generally asked limited questions and most rules were reviewed without objection. A major portion of the meeting focused on the dental rate increase rule under Act 1025. DHS said it implemented rate increases for certain pediatric, special-needs, and oral surgeon services, but not orthodontics, and it interpreted the act as applying only to oral and maxillofacial surgeons, not general dentists. The Arkansas State Dental Association and legislative sponsors testified that the intent was to cover general dentists performing oral surgery procedures for special-needs patients, estimating the broader interpretation would add about $1.5 million annually. Committee members debated the plain language of the act versus legislative intent, and the rule was reviewed, but with testimony noting the issue should be fixed in future legislation. Later items included the Healthy Moms, Healthy Babies rule adding doula and lactation consultant billing and remote monitoring benefits; an adverse decisions rule extending provider appeal time from 35 to 65 days; CNA training program updates; PASSE network-status disclosure rules; certification rules for community-based doulas and community health workers; cosmetology, massage therapy, lead-based paint, radiation, radiologic technology, and RV park rule updates. Most of these were described as technical, statutory, or federally driven changes and were reviewed without objection. The committee briefly reopened the CGM rule after a motion to expunge the prior vote, and Representative Wardlaw said he would hold the rule for further review because he believed the billing changes did not match the law’s intent. The meeting ended with no further business and adjournment.

Transcript Highlights:

• Madam President and members of the Senate, this bill is about pharmacy benefit managers.
• So, brief tutorial: what exactly is a pharmacy benefit manager, or PBM?
• In addition, they own pharmacies and specialty pharmacies and set the terms, conditions, and reimbursement
• rates for their direct competitors, which are independent, small business pharmacies.
• For reference, 19-02.1 was actually the Board of Pharmacy and Health and Human Services Code.

Keywords: 908, all

Summary: The Senate opened with prayer, the Pledge, a quorum call, and approval of journal corrections. It then handled several House messages, appointing conference committees on Senate Bills 2004 and 2006 and House Bills 1018, 1019, and 1363, and re-referring House Bill 1216 to Appropriations. The chamber also adopted amendments to House Bill 1601, which would have expanded special assistant attorney general authority for certain offices, but the bill failed on final passage after strong opposition centered on preserving the Attorney General’s control and avoiding a solution in search of a problem. A major portion of the day focused on education funding. House Bill 1369 was amended to raise per-pupil aid from 2% and 2% to 3% and 3% and to increase the school construction loan transfer from $75 million to $100 million; supporters said this would help local schools and military base projects, while opponents raised questions about special education placement language and state coordination. The bill passed 44-3. House Bill 1013, the DPI budget, was also amended extensively to adjust staffing, funding sources, grants, meal assistance, teacher training, and other education programs; it passed 45-2. House Bill 2234, dealing with Choice Ready grants, was amended to shift funding away from general funds and toward federal or other sources, but then failed on final passage after the sponsor urged a red vote. The Senate also approved House Bill 1482, restricting bond and indebtedness elections for counties, cities, school districts, and park districts to primary or general election days, and House Bill 1332, creating a value-added agriculture facility incentive program with an emergency clause. House Bill 1010, the Insurance Department budget, passed unanimously after amendments reflecting the merger of the Securities Department into Insurance and adding staff and fee changes, while House Bill 1011, the separate Securities Department budget, failed because its funding was already included in HB 1010. House Bill 1584, a major pharmacy benefit manager reform bill, passed with an enforcement fund and new licensing/enforcement structure despite debate over ERISA and market transparency. In other action, the Senate concurred in House amendments and passed Senate Bills 2226, 2230, 2069, 2082, 2387, 2385, and 2186, with SB 2186 on parenting time interference and a child custody task force passing 27-20 after debate over whether the issue should be left to the courts. Senate Bill 2234, on Choice Ready grants, and Senate Bill 2243, on driver’s license points and traffic penalties, both failed after concurrence motions were adopted but final passage votes were overwhelmingly negative. The chamber also advanced Senate Bill 2291 to conference committee consideration near the end of the transcript.

Transcript Highlights:

• of Pharmacy rules and regulations and is bigger, right?
• Centered and not contract pharmacy or one of these other providers.
• In the International District, there's a food desert, there's a pharmacy desert.
• Representative, and Madam Chair, it's the Board of Pharmacy.
• Have you considered including this in the Pharmacy Act instead?

Transcript Highlights:

• Um, pharmacy inspection. So we have three pharmacy inspectors.
• ,</c><00:13:07.519><c> you'll</c> we are the board of pharmacy, you'll we are the board of pharmacy,
• I will say the regulation of the pharmacy board is not necessarily connected to the pharmacy benefit
• ><c> were</c><00:21:41.039><c> were</c> The pharmacy benefit managers were were The pharmacy benefit
• ><c> the</c><00:22:00.320><c> pharmacy</c><00:22:00.720><c> benefit</c> connected to the pharmacy benefit

Keywords: 1189, house, all

Summary: The committee first approved the minutes from its October 3 meeting unanimously. It then reviewed follow-up status on prior performance audits, beginning with the Department of Corrections’ sex offender treatment program. DOC said all audit items from the 2016 review were resolved except one related to tracking benchmarks, progress, and recidivism. Officials explained that a new offender management system, Chorus, was recently implemented but has had rollout problems affecting operations, including restitution checks, and that they hope the system will be stable enough within about six months to begin tracking the needed metrics. Members asked about treatment inside prison and after release; DOC described in-prison treatment, parole aftercare, probation and parole oversight, administrative restrictions, and reassessment if conditions are not met. The committee next heard from OPLC on the Real Estate Commission audit. OPLC reported that all but one finding is substantially or fully resolved, with the remaining issue involving review of applicants’ adverse financial history and liabilities. The delay is tied to ongoing rulemaking, and OPLC said the commission is amending its criteria and integrating universal application procedures into board rules. The office estimated substantive completion by March 2027, with rule filing expected sooner. The committee then took up the Board of Pharmacy audit, where OPLC said most findings remain partially resolved because the board is in the middle of a major rule overhaul and a new licensing software project. Officials described a shift toward a compliance bureau and more routine, risk-informed inspections, rather than inspections driven only by complaints, and said updated manuals and forms will follow the new rules and technology. Finally, the Legislative Budget Assistant reported on ongoing audits. For special education, staff said they are writing the report, have 25 completed observations, and have expanded to 70 identified observations, with a full draft expected in the first quarter of 2026 and a final report by summer 2026. For education freedom accounts, 40 observations have been identified, 15 finalized, and a draft is expected by midspring with a fiscal committee presentation in summer. For the Doorway program, the audit plan was finalized with DHHS help, financial activity was isolated, fieldwork is expected to finish by Thanksgiving, and a draft report is planned for January or February 2026, with a final report by March or April 2026. The committee discussed scheduling its next meeting for February 6 at 10 a.m. and emphasized the value of follow-up on older audits; the meeting adjourned after members agreed the follow-up process should continue.

Transcript Highlights:

• PFAS are a complex family of more than 10,000 unique, man-made, organic compounds.
• Exposure to some PFOS compounds may increase the risk of developing cancer.
• Choosing products that do not contain these compounds is recommended.
• The examples of compounds shown on the family tree earlier allude to that vast number of compounds and
• compound variants.

Summary: The committee first received a Department of Environmental Protection presentation on Florida Forever and the sale or exchange of conservation lands. DEP described Florida Forever as the state’s main conservation land acquisition program, funded in recent years at high levels, and said most acquisitions since 2019 have been within the Florida Wildlife Corridor. The presentation also explained the legal process for disposing of conservation lands: requests are reviewed by the Acquisitions and Restoration Council, then the governor and cabinet decide whether land is no longer needed for conservation or whether an exchange provides a net conservation benefit. Senator Smith asked several questions about recent land-swap proposals, public notice, political influence, and whether any transactions had bypassed the usual sequence; DEP said applications can be withdrawn before ARC review, notice is posted seven days in advance, and the council and cabinet are the decision-makers. Senator Harrington asked about the difference between Florida Forever land sales and water management district surplus lands, and DEP said the reported 2.3 acres sold referred only to Florida Forever-funded projects. The committee then heard presentations from the Department of Health and DEP on PFAS and PFOA. DOH outlined what PFAS are, their common uses, possible health impacts, and ways Floridians can reduce exposure, including water filtration and avoiding certain products. DOH said it conducts well investigations, health consultations, fish consumption advisories, and monitoring in coordination with DEP and FWC. DEP followed with a more technical overview of PFAS regulation and cleanup, explaining federal testing and drinking-water standards, Florida’s provisional cleanup levels, and the state’s response at contaminated sites, including bottled water and filtration for affected residents. Senators asked about testing requirements for public systems and private wells, disposal of used filters, and how federal rulemaking and litigation could affect Florida’s standards; DEP said public systems are required to test under EPA monitoring rules, private wells are not directly required to test, and Florida may adopt its own standards if federal action does not occur by the statutory deadline. Finally, the committee took up SB 150, which would designate the flamingo as the state bird and the scrub jay as the state songbird. The sponsor argued the bill better reflects Florida’s identity and conservation values, noting the flamingo’s iconic status and the scrub jay’s status as a Florida-only species. Members asked lighthearted questions about mockingbirds, flamingo color, and feeding costs, and an appearance card was filed in support by the Association of Zoos and Aquariums. The committee debated the bill briefly and then passed SB 150 favorably by roll call vote, with all members present voting yes except Senator DiCeglie, who was excused.

Transcript Highlights:

• PBMs own health plans, the pharmacy down the street, the mail-order pharmacy to where they steer patients
• pharmacies to close.
• Even before the Rite Aid closures, numerous community pharmacies were closing, creating pharmacy deserts
• and chain pharmacies and affiliate pharmacies.
• How those reimbursement rates differ between independent pharmacies and chain pharmacies and affiliate

Summary: The committee heard testimony on several bills, beginning with SB 41 by Senator Wiener, which would regulate pharmacy benefit managers by increasing transparency, banning patient steering and spread pricing, and requiring full pass-through of rebates. Supporters, including independent pharmacists and health advocates, said PBM practices are driving up drug costs and closing neighborhood pharmacies. Opponents from PBM and health plan groups argued the bill overlaps with recently enacted licensing and reporting requirements, would not lower consumer prices, and may be preempted by ERISA. Members discussed confidentiality issues, consumer savings, and the relationship between SB 41 and the new budget trailer bill; the author asked for an aye vote. The committee then took up SB 378, also by Senator Wiener, aimed at online marketplaces that advertise illegal intoxicating hemp and unlicensed cannabis products. Supporters from labor, public health, and the licensed cannabis industry said online sales are undermining regulated businesses and exposing children to unsafe products. Opponents from tech and hemp industry groups warned the bill is overbroad, could sweep in general-purpose platforms and lawful hemp wellness products, and raises Dormant Commerce Clause and First Amendment concerns. The author said he would narrow the bill, remove industrial hemp references, and address strict liability and standing issues; members largely focused on how to target illegal products without capturing lawful marketplaces. SB 243 by Senator Padilla addressed AI companion chatbots, with supporters including Common Sense Media and transparency advocates warning that these systems can be addictive, manipulative, and dangerous for minors and vulnerable users, citing studies and the death of a Florida teenager. The bill would require disclosures, anti-addiction design limits, self-harm protocols, audits, reporting, and a private right of action. Tech and business groups opposed the measure as overly broad and said its definitions could sweep in general-purpose AI tools; several members supported the goal but questioned the breadth of the definitions and the private right of action. Finally, SB 522 by Senator Wahab would extend just-cause eviction protections to rental units that were previously covered by the Tenant Protection Act but were destroyed in disasters and later rebuilt. Supporters, including Los Angeles city officials and tenant advocates, said the bill would help keep displaced renters housed after wildfires and other disasters. Apartment and realtor groups opposed it, arguing it would remove a key exemption needed to finance rebuilding and could discourage post-disaster reconstruction. Members expressed support for tenant protections in disaster areas, and the author asked for an aye vote.

Transcript Highlights:

• , and we call that a pharmacy desert.
• , and we call that a pharmacy desert.
• that if that one pharmacy closed, that area would... ...such that if that one pharmacy closed, that
• types of pharmacies?
• I do have that mom-and-pop pharmacy... ...mom-and-pop pharmacy that is right in Barnstable, but they're

Summary: The hearing was a Joint Committee on Ways and Means budget session on health and human services, held in Clinton and opened with remarks from the House and Senate co-chairs, local officials, and committee members. The chairs emphasized the importance of hearing directly from agencies about the Commonwealth’s health care and human services budget needs, thanked Clinton for hosting, and introduced the day’s panels, beginning with the Executive Office of Health and Human Services (EOHHS) and then MassHealth. Secretary Kiame Mahania presented Governor Healey’s FY27 EOHHS budget, describing a $33.7 billion request driven largely by non-discretionary cost growth, caseload increases, and federal uncertainty. He highlighted targeted investments in foster parent reimbursement, family resource centers, maternal health, food assistance, immigrant legal services, and workforce rates, while warning that federal cuts and the Trump administration’s One Big Beautiful Bill Act could strip billions from state health funding. Members questioned him about primary care shortages, federal program integrity audits, ConnectorCare, regional health disparities, and the proposed cap on adult dental coverage; he defended the cap as a difficult but necessary cost-control measure and said the administration would continue cooperating with federal partners. Undersecretary Michael Levine then testified for MassHealth, saying the agency faces two major challenges: rapid cost growth and looming federal changes. He outlined a $22.7 billion gross MassHealth budget and proposed actions including a moratorium on new expansions, capping adult dental benefits at $1,000, ending GLP-1 coverage for weight loss only, reducing care management spending to peer-state levels, and convening work groups to slow growth in personal care attendant, adult foster care, and adult day health programs. He also warned that federal policy changes could cause about 300,000 residents to lose coverage by 2030 and reduce federal revenue by about $3.5 billion, and said MassHealth would use outreach and systems changes to help eligible members stay covered. Members raised concerns about the impact of these cuts on homeless care, preventive services, dental access, GLP-1s, and regional hospital and specialist shortages, while Levine argued the proposals were aimed at preserving core coverage and sustainability.

Transcript Highlights:

• A temporary two-year annual non-compounding payment to eligible para retirees.
• So adding to the compounding COLA is very costly. We're looking at another 15 to 17 years.
• The only difference is we now give a compounding COLA.
• , they would still get the compounding effect of that.
• But that 2% does not compound. So it's not truly a 4.5% bump. Thank you so much, Madam Chair.

Keywords: 996, all

Transcript Highlights:

• partnership with my friend here next to me, our students can pursue programs in surgical technology, pharmacy
• I think this work sort of compounds and adds to the investment that we've already made in some of those

Keywords: 995, all

Summary: The Joint Committee on Community Development and Small Business held its final hearing of the session on H. 5187 and S. 3022, the Enough Act, with Chair Andy Vargas and Senator Adam Gomez opening by thanking committee members and stakeholders for their work during the session. The bills were described as a grant-based, place-based anti-poverty initiative intended to support cradle-to-career services by funding local nonprofits, schools, community organizations, and backbone entities that can coordinate housing, education, health, workforce, and family supports in high-poverty neighborhoods. Testimony was overwhelmingly in support of the bills. Speakers including Strategies for Children, Chelsea Public Schools, Bunker Hill Community College, Senator Sal DiDomenico, Rep. Kate Lipper-Garabedian, Rep. Antonio Cabral, the Harlem Children’s Zone’s Kwame Owusu Kesse and Jeffrey Canada, former Education Secretary Paul Reville, AFT Massachusetts, United Way, the Boston Foundation, Give Black Alliance, Eastern Bank Foundation, and others argued that poverty is a systems issue that schools alone cannot solve. They emphasized the need for local control, community voice, coordinated services, and long-term public-private investment, often citing examples from Chelsea, New Bedford, Springfield, Lowell, Boston, and other communities, as well as the Harlem Children’s Zone and Maryland’s similar model. Committee members asked several questions about how the bill would function in practice, including what organizations would do on day one, how it would interact with existing efforts like community schools, McKinney-Vento, and the Student Opportunity Act, and how it would be sustained over time. Witnesses said the act would help create or strengthen backbone organizations, reduce duplication, align existing resources, and leverage philanthropy and future revenue sources for long-term sustainability. No vote was taken during the hearing, but multiple speakers urged the committee to report the bill favorably and quickly.

Transcript Highlights:

• We can track pharmacies, but the pharmacies are not the ones filling the prescriptions; the pharmacists
• and a pharmacy is supposed to be secure from outside entities.
• : it controls pharmacies, but you have pharmacies within assisted living facilities or nursing facilities
• : it controls pharmacies, but you have pharmacies within assisted living facilities or nursing facilities
• controls pharmacies, but you have pharmacies within assisted living facilities or nursing facilities

Keywords: 1182, all

Transcript Highlights:

• , and we call that a pharmacy desert.
• that if that one pharmacy closed, that that area would Such that if that one pharmacy closed, that that
• types of pharmacies?
• I do have that mom-and-pop pharmacy. ...mom-and-pop pharmacy that is right in Barnstable, but they're
• So you think of your big chain pharmacy, they're likely connected to a big PBM. ...big chain pharmacy

Keywords: 1212, all

Transcript Highlights:

• Next item up is the January 2026 pharmacy formulary recommendations.
• Next item up is the January 26th pharmacy formulary recommendations.
• His question was whether affiliate pharmacies were being paid more than independent pharmacies within
• being paid more than independent pharmacies.
• are being affected differently than affiliated pharmacies.

Keywords: 1204, all

Transcript Highlights:

• Item number two is the December 2025 pharmacy formulary recommendations.
• Next item up is the January 2026 pharmacy formulary recommendations.
• Next item up is the January 2026 pharmacy formulary recommendations.
• Moving to the February 2026 pharmacy formulary recommendations.
• more than we're paying our independent pharmacies within the plan?

Summary: The State Insurance Programs Oversight Subcommittee met to review and approve several Employee Benefits Division (EBD) and pharmacy formulary actions. Grant Wallace, director of EBD and the Office of Property Risk, presented a $280,000 Boston Consulting Group contract to help develop the third-party administration RFP, and the committee approved it. The committee also approved the December 2025, January 2026, and February 2026 pharmacy formulary recommendations, along with February 2026 medical drug recommendations. The formulary changes focused on removing prior authorization for injectable migraine CGRPs, replacing a discontinued capsule with a tablet, updating items for FDA guidance, and leaving some drugs not covered when lower-cost alternatives or insufficient efficacy data existed. For February 2026, EBD recommended removing Skyrizi and Renvoke in favor of lower-cost biosimilars and other alternatives, re-tiering several drugs to encourage generics, adding an anti-seizure medication developed by the Department of Defense, and adding a subcutaneous version of Keytruda for faster administration. The medical drug list similarly shifted toward biosimilars and aligned coverage for Skyrizi and Renvoke across pharmacy and medical settings. Members raised broader questions about the impact of new pharmaceutical discount programs such as Trump RX and Mark Cuban Cost Plus, as well as concerns about PBM compliance and whether Navitus might be violating state law or paying affiliate pharmacies more than independent pharmacies. Wallace said the new programs and their effects were still being studied, that EBD was working with Navitus to evaluate pricing opportunities, and that Navitus had said it was in compliance with Rule 118, though additional research and auditing were underway. All items were approved by voice vote, and the meeting adjourned after no further business.

Transcript Highlights:

• This instrument provides relative to pharmacy benefit managers to provide for definitions.
• Thus streamlining the process for pharmacy appeals.
• It prohibits using a formulary to ban the use of certain pharmacies by an enrollee.
• It prohibits using formulary to ban the use of certain pharmacies by an enrollee.
• Apeic effective rate pricing: pharmacies can't predict reimbursement.

Summary: The House Insurance Committee met on April 29 with a quorum present and took up several insurance and health care-related bills. SB 192, a dental reimbursement bill, was amended to allow dentists to opt in electronically to credit-card payment methods and to clarify applicability and effective date; it was reported as amended. SB 84 would require prostate cancer screening coverage for men over 40 under current clinical guidelines and prohibit cost-sharing; supporters from the American Cancer Society said Louisiana has a high incidence of prostate cancer and that out-of-pocket costs deter early screening. The committee adopted amendments and reported the bill as amended. SB 275, dealing with reimbursement and network participation for certified registered nurse anesthetists, drew support from nursing and hospital groups and was reported favorably. SB 169, a cleanup bill on biomarker testing, was also amended and reported. The committee spent substantial time on SB 401, which creates a temporary prescription drug affordability board to review pricing data on selected drugs and report findings to the legislature. Supporters said the board would improve transparency and help lawmakers understand drug pricing trends; opponents raised concerns about confidentiality, market effects, and the lack of a defined policy outcome beyond reporting. Amendments narrowed the scope, added confidentiality protections, and removed opposition cards, and the bill was reported as amended. SB 387, a major PBM reform bill tied to SB 401, would change PBM compensation, rebate handling, formulary practices, audits, and appeals, while excluding ERISA plans after discussion and amendment. Supporters argued it would curb spread pricing and other practices that raise costs, while opponents from the Pelican Institute and PCMA warned it would interfere with private contracts, reduce flexibility, and could raise premiums or disrupt city, school board, and small-group plans. After extensive debate and a roll call, SB 387 was reported with amendments by a 10-4 vote. The committee also considered SB 241, which requires certain insurance adjusters and public adjusters to include license numbers in written communications. After amendments limiting the requirement to individual licenses and removing one statutory reference, the bill was reported as amended. Throughout the meeting, members and witnesses repeatedly discussed the need for transparency in drug pricing and PBM practices, the role of ERISA and non-ERISA plans, and potential impacts on public employers and consumers.

Transcript Highlights:

• As Chair Beerman pointed out, we did some phenomenal work with hospitals and pharmacy this year.
• Chair Berman replied that the directed pharmacy payment will not need federal approval.
• It will limit the pharmacies to non-PBM-owned pharmacies.
• , directed pharmacy dispensing payment, how<00:14:14.240><c> that</c><00:14:14.480><c> works,</c><00:
• It will limit the pharmacies to non-PBM-owned pharmacies.

Bills: HF2436, HF2435

Keywords: child welfare, economic assistance, child care, grant program, video security cameras, healthcare, dementia services, public health funding, opioid prevention, women's health, community health boards, mental health, 1183, house

Transcript Highlights:

• We're also looking at pharmacy benefit managers, so PBM, pharmacy benefit managers, cost controls, and
• Five states have a pharmacy carve-out for managed care.
• It basically took out a lot of our pharmacies, our mom-and-pop pharmacies.
• And one of the pharmacies that also closed off was Rupi's Drug.
• You talked about pharmacies. Tell us about how it affected patients.

Transcript Highlights:

• </c><00:40:09.960><c> my</c> insulin to our contract pharmacies my insulin to our contract pharmacies
• </c> ship it there we have only one Pharmacy ship it there we have only one Pharmacy on<00:40:35.640>
• </c> managed list of practicing pharmacy managed list of practicing pharmacy technicians<00:50:32.119
• </c><00:51:55.960><c> um</c> so I could get home to my Pharmacy um so I could get home to my Pharmacy
• </c> licensed pharmacists our pharmacy licensed pharmacists our pharmacy technicians<00:52:51.760><c>

Keywords: 910, house, all

Summary: The joint hearing covered HB 553 on biomarker testing coverage, HB 556 on colorectal cancer screening access, and later HB 712 on 340B drug pricing. For HB 553, the American Cancer Society Cancer Action Network, patient advocates Natalie Heyman and Susan Hirano, a surgical oncologist, and the American Lung Association strongly supported the bill, arguing that biomarker testing should be covered when ordered by a doctor and guided by current evidence. DHS and several insurers offered comments and requested amendments, with DHS saying it appreciated the intent but wanted changes. The committees then voted to pass HB 553 with amendments, including a House draft and a defective date of July 1, 3000; both the House Health and Human Services and Homelessness committees adopted the recommendation unanimously. For HB 556, testimony focused on closing gaps in colorectal cancer screening, especially for uninsured and underinsured patients who can get stool-based screening but then cannot access follow-up colonoscopies. Community Clinic of Maui, ACS CAN, and the American Cancer Society supported the bill, with ACS CAN urging a program similar to the breast and cervical cancer control program and offering amendments. DHS requested that the program and appropriation not conflict with executive budget priorities, and the committees noted technical amendments, a defective date, a blank appropriation amount, and corrections changing Medicare references to Medicaid. HB 556 was also passed with amendments by both committees. The hearing then moved to HB 712 on 340B drug pricing and contract pharmacies. The Department of Health and the Attorney General’s office expressed concern that the bill would require the state to regulate private commercial activity and said the department lacked the expertise and resources to implement it as written, suggesting it might belong in a different statutory section. In contrast, PhRMA opposed the bill, while Hawaii Pacific Health and Hawaii Island Community Health Center supported it, saying 340B savings are important for hospital services and patient access to low-cost medications, especially where manufacturers have restricted shipments to contract pharmacies. No vote on HB 712 was taken in the portion provided.

Transcript Highlights:

• Leveraging the accessibility of pharmacies and the broad pharmacy network across our rural state, these
• Leveraging the accessibility of pharmacies and the broad pharmacy network across our rural state, these
• It's the pharmacy benefit managers by controlling the money.
• can't have... ...pharmacy now and I said, I lost my insurance.
• The system, as it currently is, is pharmacy benefit managers decide.

Keywords: 908, all

Summary: The committee first took up Senate Bill 2401, which would require physicians to complete continuing education on nutrition and metabolic health as part of the state’s rural health transformation effort. HHS supported the bill, saying it would help physicians better address chronic disease and preserve federal grant points tied to the state’s application. A member of the public also testified in favor, arguing that better nutrition education could improve diabetes outcomes and reduce costs. The committee then adopted an amendment to add the Board of Occupational Therapy Practice to the background-check statute so the occupational therapy compact could proceed, and it passed the bill as amended on a roll call vote. The committee next heard House Bill 1621, which would require the Presidential Fitness Physical Fitness Test in elementary, middle, and high school physical education courses. HHS said the bill was part of the rural health transformation application and could help preserve federal funding, but members raised many questions about the test’s criteria, adaptive options for students with disabilities, equipment needs, and whether the bill should apply to non-public schools. Senator Clemens offered an amendment to limit the requirement to public schools, but it failed. Senator Hogan then offered an amendment to clarify exemptions and allow DPI to align implementation with federal guidance; that amendment passed. A further amendment adding language allowing DPI to establish criteria for and exceptions to the test also passed. The committee then approved the bill as amended on a roll call vote. The committee also considered House Bill 1622, which joins North Dakota to the physician assistant licensure compact. HHS said the compact would improve access to care, especially in rural areas, support military families, and help preserve rural health transformation funding. Members noted the compact had been discussed in a prior session and that many earlier concerns had been resolved. After brief discussion about the compact process and its consistency with other interstate compacts, the committee voted to do pass the bill. Finally, the committee began Senate Bill 2402, which expands pharmacists’ prescriptive authority and therapeutic substitution powers. HHS and the Board of Pharmacy supported the bill as a way to improve access to care and maintain rural health transformation funding. Senator Roers introduced a detailed amendment negotiated with the Board of Medicine and Board of Pharmacy to narrow and clarify the bill, including notification requirements, limits on certain drug categories, and patient-protection language for therapeutic substitution. The Board of Pharmacy then testified in support of the broader bill and explained the CLIA-waived testing provisions and the repeal of the older, narrower pharmacist-testing language. The hearing and amendment discussion were still underway when the transcript ended.